Thaler HT - Search Results

1

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ. Howe LR, et al. Among authors: thaler ht. Cancer Res. 2002 Oct 1;62(19):5405-7. Cancer Res. 2002. PMID: 12359744

2

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.

Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ. Patel MI, et al. Among authors: thaler ht. Clin Cancer Res. 2005 Mar 1;11(5):1999-2007. doi: 10.1158/1078-0432.CCR-04-1877. Clin Cancer Res. 2005. PMID: 15756026

3

Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.

Altorki NK, Port JL, Zhang F, Golijanin D, Thaler HT, Duffield-Lillico AJ, Subbaramaiah K, Dannenberg AJ. Altorki NK, et al. Among authors: thaler ht. Clin Cancer Res. 2005 Jun 1;11(11):4191-7. doi: 10.1158/1078-0432.CCR-05-0108. Clin Cancer Res. 2005. PMID: 15930356

4

HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.

Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, Cardiff RD, Newman RA, Yang P, Thaler HT, Muller WJ, Hudis C, Brown AM, Hla T, Subbaramaiah K, Dannenberg AJ. Howe LR, et al. Among authors: thaler ht. Cancer Res. 2005 Nov 1;65(21):10113-9. doi: 10.1158/0008-5472.CAN-05-1524. Cancer Res. 2005. PMID: 16267038

5

Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma.

Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ. Gross ND, et al. Among authors: thaler ht. Clin Cancer Res. 2007 Oct 1;13(19):5910-7. doi: 10.1158/1078-0432.CCR-07-0352. Clin Cancer Res. 2007. PMID: 17908987

6

Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer.

Yu AF, Yadav NU, Lung BY, Eaton AA, Thaler HT, Hudis CA, Dang CT, Steingart RM. Yu AF, et al. Among authors: thaler ht. Breast Cancer Res Treat. 2015 Jan;149(2):489-95. doi: 10.1007/s10549-014-3253-7. Epub 2015 Jan 1. Breast Cancer Res Treat. 2015. PMID: 25552363 Free PMC article.

7

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Butler LM, et al. Among authors: thaler ht. Cancer Res. 2000 Sep 15;60(18):5165-70. Cancer Res. 2000. PMID: 11016644

8

Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction.

Yu AF, Yadav NU, Eaton AA, Lung BY, Thaler HT, Liu JE, Hudis CA, Dang CT, Steingart RM. Yu AF, et al. Among authors: thaler ht. Oncologist. 2015 Oct;20(10):1105-10. doi: 10.1634/theoncologist.2015-0125. Epub 2015 Aug 3. Oncologist. 2015. PMID: 26240135 Free PMC article.

9

Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.

Jaehne J, Urmacher C, Thaler HT, Friedlander-Klar H, Cordon-Cardo C, Meyer HJ. Jaehne J, et al. Among authors: thaler ht. J Cancer Res Clin Oncol. 1992;118(6):474-9. doi: 10.1007/BF01629433. J Cancer Res Clin Oncol. 1992. PMID: 1352299

10

Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.

Mahmood U, Alfieri AA, Thaler H, Cowburn D, Koutcher JA. Mahmood U, et al. Cancer Res. 1994 Sep 15;54(18):4885-91. Cancer Res. 1994. PMID: 8069854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters